You searched for oncology.
Page 3 of 344 results
Oncology Clinical Trial: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Clinical Trial Protocol # ANBL00B1 | Biology/Genomics, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Clinical Trial Protocol # ACCL0933 | Leukemia/Lymphoma, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Fertility Preservation in Women and Girls with Cancer
Clinical Trial | Adolescents and Young Adults, Fertility, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Clinical Trial | Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Childhood Cancer Survivor Study
Clinical Trial | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Clinical Trial Protocol # 10-CBA | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant | Contact (714) 509-8646
Oncology Clinical Trial: A Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Trial | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant | Contact (714) 509-8646
Oncology Clinical Trial: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Clinical Trial Protocol # ANBL1232 | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Collection of Samples and Data for the National Marrow Donor Program Repository
Clinical Trial | Bone Marrow Transplant/Hematopoietic Stem Cell Transplant | Contact (714) 509-8646
Oncology Clinical Trial: A Phase II Study of Dasatinib Therapy in Children and Adolescents with Newly Diagnosed Chronic Phase CML or with Ph+ Leukemias Resistant or Intolerant to Imatinib
Clinical Trial Protocol # 90325 | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer, oncology | Contact (714) 509-8646
Oncology Clinical Trial: Approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer.
Clinical Trial | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Clinical Trial Protocol # AOST1421 | Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Ketogenic Diet as a Complementary Metabolic Therapy in Pediatric Recurrent/Refractory Solid Tumors including Central Nervous System (CNS) Tumors
Clinical Trial | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Clinical Trial Protocol # AALL0932 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Treatment for Advanced B-Cell Lymphoma
Clinical Trial | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Study of a Tool for Advanced Care Planning in Young Adults Cancer and Other Life Threatening Illnesses
Clinical Trial | Adolescents and Young Adults, Recurrent/Refractory Cancer, Supportive Care, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Clinical Trial Protocol #: AAML1531 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Project – Every Child for Younger Patients With Cancer
Clinical Trial Protocol # APEC14B1 | Biology/Genomics, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Clinical Trial Protocol #CMX001-351 | Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: A Study of Pembrolizumab (MK-3475) in Pediatric Participants With Advanced Melanoma or Advanced, Relapsed, or Refractory PD-L1-Positive Solid Tumors or Lymphoma (MK-3475-051/KEYNOTE-051)
Clinical Trial Protocol # MK3475-051/ADVL1621 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Fertility Understanding through Registry and Evaluation (FUTuRE Fertility)
Clinical Trial | Adolescents and Young Adults, Fertility, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
Clinical Trial Protocol #T2012-002 | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Clinical Trial Protocol # AALL05B1 | Biology/Genomics, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: A Study on Drug Monitoring of Asparaginase Activity in Pediatric Patients with Acute Lymphoblastic Leukemia
Clinical Trial | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Clinical Trial Protocol # AOST1521 | Recurrent/Refractory Cancer, solid Tumors | Contact (714) 509-8646
